Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | RETICINE PHARMAIDS LIMITED | 5 | - |
| 2 | Schedule 2 | RETICINE PHARMAIDS LIMITED | 5 | - |
| 3 | Schedule 3 | RETICINE PHARMAIDS LIMITED | 5 | - |
| 4 | Schedule 4 | RETICINE PHARMAIDS LIMITED | 5 | - |
| 5 | Schedule 5 | RETICINE PHARMAIDS LIMITED | 5 | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
31 Dec 2024, 11:00 amClosed
Title1
Title2
Title 3
Title 4
Title 5
7217977
GEM/2024/B/5678900
Two Packet Bid
Title1
15 days
West Bengal; Darjeeling
Item wise evaluation
BOQ
6 documents required · 6 mandatory
1 yrs
₹31
10%
Exempted
31 Dec 2024
9 Dec 2024
31 Dec 2024
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|---|
| 1 | Title1 | Inj Calcium borogluconate 25% with magnesium hypophosphite 5% and dextrose 20%
Bott of 450ml | 40 | Bott | Darjeeling | 15 | |
| 2 | Title2 | Toldimfos sodium Inj | 80 | vial | Darjeeling | 15 | |
| 3 | Title 3 | Meloxicam Inj | 100 | vial | Darjeeling | 15 | |
| 4 | Title 4 | Inj Neurobion | 200 | Ampoule | Darjeeling | 15 | |
| 5 | Title 5 | Strepto-penicillin for suspension inj | 100 | vial | Darjeeling | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7217977.pdf
GEM_BID
veterinary_medicine_specifications_2024-12-09-10-29-05_894b1e480ec3007d79defa9a19d65013.pdf
BOQ
boq_item_final_2024-12-09-10-29-05_78488a8da1cd15488cc66f9ebdad6172.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .